Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Molecular Characterization of a Novel Splicing Mutation underlying Mucopolysaccharidosis (MPS) type VI-Indirect Proof of Principle on Its Pathogenicity.

Coutinho MF, Encarnação M, Matos L, Silva L, Ribeiro D, Santos JI, Prata MJ, Vilarinho L, Alves S.

Diagnostics (Basel). 2020 Jan 21;10(2). pii: E58. doi: 10.3390/diagnostics10020058.

2.

RNA Therapeutics: How Far Have We Gone?

Coutinho MF, Matos L, Santos JI, Alves S.

Adv Exp Med Biol. 2019;1157:133-177. doi: 10.1007/978-3-030-19966-1_7. Review.

PMID:
31342441
3.

Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders.

Coutinho MF, Santos JI, Matos L, Alves S.

Diseases. 2016 Nov 9;4(4). pii: E33. doi: 10.3390/diseases4040033. Review.

4.

Coutinho et al. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders. Int. J. Mol. Sci. 2016, 17, 1065.

Coutinho MF, Santos JI, Alves S.

Int J Mol Sci. 2017 Jan 17;18(1). pii: E178. doi: 10.3390/ijms18010178.

5.

Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.

Coutinho MF, Santos JI, Alves S.

Int J Mol Sci. 2016 Jul 4;17(7). pii: E1065. doi: 10.3390/ijms17071065. Review. Erratum in: Int J Mol Sci. 2017 Jan 17;18(1):.

6.

Restoring TGFβ1 pathway-related microRNAs: possible impact in metastatic prostate cancer development.

Santos JI, Teixeira AL, Dias F, Gomes M, Nogueira A, Assis J, Medeiros R.

Tumour Biol. 2014 Jul;35(7):6245-53. doi: 10.1007/s13277-014-1887-z. Epub 2014 Apr 25. Review.

PMID:
24763824

Supplemental Content

Loading ...
Support Center